Biotinylated Human IL-4 Protein, Avitag™,His Tag (MALS verified)
分子别名（Synonym）
IL4, BCGF1, BSF1
表达区间及表达系统（Source）
Biotinylated Human IL-4, Avitag,His Tag (IL4-H82E0) is expressed from human 293 cells (HEK293). It contains AA His 25 - Ser 153 (Accession # AAH67514).
Predicted N-terminus: His 25
蛋白结构（Molecular Characterization）
This protein carries an Avi tag (Avitag™) at the C-terminus, followed by a polyhistidine tag.
The protein has a calculated MW of 17.6 kDa. The protein migrates as 23-25 kDa under reducing (R) condition, and 20-23 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE) due to glycosylation.
标记（Labeling）
Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.
蛋白标记度（Protein Ratio）
Passed as determined by the HABA assay / binding ELISA.
纯度（Purity）
>95% as determined by SDS-PAGE.
制剂（Formulation）
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法（Reconstitution）
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景介绍
白细胞介素-4（IL-4）是一种诱导初始辅助T细胞（Th0细胞）分化为Th2细胞的细胞因子。在Th2型免疫应答（尤其见于过敏和寄生虫感染）产生的IL-4与IL-13作用下，巨噬细胞可发生替代性激活。IL-4是白细胞介素4受体的配体，而该受体还能结合IL-13，这导致二者产生显著的功能重叠。信号转导与转录激活因子6（STAT6）被证实在该细胞因子的免疫调节信号传递中起核心作用。最新研究发现，在Itk、KLF2、CBP及Id3等基因缺陷小鼠品系中，IL-4能在无抗原预刺激的情况下，介导胸腺内先天CD8阳性T细胞的发育。
关键字： IL-4;IL-4蛋白;IL-4重组蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group（股票代码：301080）是成立于2010年的跨国生物科技公司，是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球，横跨亚洲、北美洲、欧洲，在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家，与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。